Viyash Scientific Limited

Viyash Scientific Limited (VIYASH) is a small-cap Healthcare company valued at ₹9,983 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Viyash Scientific Limited last traded at ₹225.9, modestly down 0.01% on the day.

Recent developments

On 2026-07-22, Viyash Scientific signed a supply agreement to acquire BioForLife Italia for €16.97 million, marking a key step in its international expansion strategy.

Financial performance

The company's business is improving, with annual revenue rising 13.7% and net profit surging 1304.1%. The latest quarter saw revenue grow 19.5% and net profit jump 114.3% compared to the same quarter a year earlier. Net profit margin expanded 6.0 percentage points to 6.6%, while return on equity remained at 6.1%.

Valuation multiples

The stock trades at 55.2 times earnings, a premium to the Healthcare median of 32.0, 4.08 times book value. It yields 0.2%.

Things to watch

The stock is 22.2% below its 52-week high. Domestic institutional holding fell 4.24 percentage points in the quarter. Net profit margin, though up, remains low at 6.6%.

Where it stands

The company has delivered strong growth in both revenue and net profit, with the latest quarter showing significant improvement. The most notable movement was the 1304.1% annual increase in net profit. The stock is currently 22.2% below its 52-week high.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.